EH
Therapeutic Areas
Zura Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tibulizumab (ZB-106) | Systemic Sclerosis | Phase 2 |
| Crebankitug (ZB-168) | Autoimmune/Inflammatory Diseases (Undisclosed) | Phase 1 |
| Torudokimab (ZB-880) | Autoimmune/Inflammatory Diseases (Undisclosed) | Phase 1 |